Simcere Pharmaceutical Group (NYSE: SCR) today reported that its subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. has suspended production ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE